Deep Learning-Enabled, Detection of Rare Circulating Tumor Cell Clusters in Whole Blood Using Label-free, Flow Cytometry

Metastatic tumors have poor prognoses for progression-free and overall survival for all cancer patients. Rare circulating tumor cells (CTCs) and rarer circulating tumor cell clusters (CTCCs) are potential biomarkers of metastatic growth, with CTCCs representing an increased risk factor for metastasi...

Descripción completa

Detalles Bibliográficos
Autores principales: Vora, Nilay, Shekar, Prashant, Esmail, Michael, Patra, Abani, Georgakoudi, Irene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418242/
https://www.ncbi.nlm.nih.gov/pubmed/37577660
http://dx.doi.org/10.1101/2023.08.01.551485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418242/
https://www.ncbi.nlm.nih.gov/pubmed/37577660
http://dx.doi.org/10.1101/2023.08.01.551485

Ejemplares similares